Processa Pharmaceuticals, Inc. Increase (Decrease) in Deposits
Processa Pharmaceuticals, Inc. (PCSA) reported Increase (Decrease) in Deposits of $227.66 thousand for the 12-month period ending 2017-12-31, per its 10-K/A filed 2019-04-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeposits · last filed 2019-04-08
- Processa Pharmaceuticals, Inc. increase (decrease) in deposits for the quarter ending 2017-12-31 was $0.00.
- Processa Pharmaceuticals, Inc. increase (decrease) in deposits for the quarter ending 2017-09-30 was $0.00.
- Processa Pharmaceuticals, Inc. increase (decrease) in deposits for the quarter ending 2017-06-30 was $0.00.
- Processa Pharmaceuticals, Inc. increase (decrease) in deposits for the quarter ending 2017-03-31 was $227.66K.
- Processa Pharmaceuticals, Inc. increase (decrease) in deposits for fiscal 2017 was $227.66K.
- Processa Pharmaceuticals, Inc. increase (decrease) in deposits for fiscal 2016 was -$227.66K.
| Period end | Increase (Decrease) in Deposits 3 month | Increase (Decrease) in Deposits 6 month | Increase (Decrease) in Deposits 9 month | Increase (Decrease) in Deposits 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-08 | $0.00 derived: sum of 2 quarters · filed 2019-04-08 | $0.00 derived: sum of 3 quarters · filed 2019-04-08 | $227.66K 10-K/A · filed 2019-04-08 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-11-14 | $227.66K 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $227.66K 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $227.66K 10-Q · filed 2018-05-21 | |||
| 2016-12-31 | -$227.66K 10-K · filed 2018-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |